Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caribou Biosciences (CRBU) Research & Development: 2020-2025

Historic Research & Development for Caribou Biosciences (CRBU) over the last 6 years, with Sep 2025 value amounting to $22.4 million.

  • Caribou Biosciences' Research & Development fell 26.36% to $22.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $116.1 million, marking a year-over-year decrease of 11.36%. This contributed to the annual value of $130.2 million for FY2024, which is 16.13% up from last year.
  • Latest data reveals that Caribou Biosciences reported Research & Development of $22.4 million as of Q3 2025, which was down 19.11% from $27.7 million recorded in Q2 2025.
  • Over the past 5 years, Caribou Biosciences' Research & Development peaked at $35.5 million during Q1 2025, and registered a low of $10.2 million during Q1 2021.
  • Moreover, its 3-year median value for Research & Development was $30.4 million (2024), whereas its average is $29.8 million.
  • Its Research & Development has fluctuated over the past 5 years, first soared by 156.20% in 2021, then decreased by 26.36% in 2025.
  • Over the past 5 years, Caribou Biosciences' Research & Development (Quarterly) stood at $15.1 million in 2021, then soared by 70.31% to $25.7 million in 2022, then climbed by 21.54% to $31.3 million in 2023, then decreased by 2.61% to $30.5 million in 2024, then decreased by 26.36% to $22.4 million in 2025.
  • Its Research & Development was $22.4 million in Q3 2025, compared to $27.7 million in Q2 2025 and $35.5 million in Q1 2025.